Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Antiplatelet Therapy and Cardiovascular Diseases

37 ta ish

  1. Efficacy of ticagrelol in patients with chronic coronary syndrome and type 2 diabetes mellitus after percutaneous coronary interventions

    D. Orziev, A. Abdullaev, Bakhromkhon Alyavi +1

    MaqolaAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20230 iqtibos
    ABI

  2. Effect of combined carriage of polymorphic markers ApoE (Ε2/Ε3/Ε4) and ApoA1 (G-75A) on the ApoB/ApoA-I ratio in CAD patients in the Uzbek population

    Р Алиева, Aleksandr B. Shek, А. А. Абдуллаев +4

    MaqolaAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20230 iqtibos
    ABI

  3. The state of the prostacyclin-thromboxane system in patients after aorto-coronary bypass surgery

    R. Yu. Kattakhanova, U. N. Kanataeva

    MaqolaAntiplatelet Therapy and Cardiovascular DiseasesBIO Web of Conferences20230 iqtibos
    ABI

  4. The Impact of Cholesterol on Stroke Outcomes: A Cross-Sectional Analysis in Central Java

    Yulita Maulani, TOIROV Abdukhamit Suvonovich, Emma Ismawatie +1

    MaqolaAcute Ischemic Stroke ManagementSriwijaya Journal of Neurology20240 iqtibos
    ABI

  5. MODERN SOLUTIONS FOR THE USE OF ANTICOAGULANTS IN MYOCARDIAL INFARCTION AND ARRHYTHMIAS

    Turayev H.N, Khurramov Bobir Kholmurodovich

    MaqolaAtrial Fibrillation Management and OutcomesJournal of Medical Genetics and Clinical Biology20250 iqtibos
    ABI

  6. Evaluation of the efficacy of treatment using SGLT2 inhibitors in patients with acute myocardial infarction

    Dilafruz Akhmedova, Раиса Тригулова

    MaqolaDiabetes Treatment and ManagementAtherosclerosis20250 iqtibos
    ABI

  7. DUAL ANTIAGGREGANT TERAPIYANING YURAK-QON TOMIR ASORATLARINI KAMAYTIRISHDAGI O'RNI VA INDIVIDUAL YONDASHUV IMKONIYATLARI

    Nematova Nasiba Baxodirxon qizi,Abdulkhamidov Abduvali Alisher o'g'li

    MaqolaAntiplatelet Therapy and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  8. DUAL ANTIAGGREGANT TERAPIYANING YURAK-QON TOMIR ASORATLARINI KAMAYTIRISHDAGI O'RNI VA INDIVIDUAL YONDASHUV IMKONIYATLARI

    Nematova Nasiba Baxodirxon qizi,Abdulkhamidov Abduvali Alisher o'g'li

    MaqolaAntiplatelet Therapy and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  9. CLINICAL AND ANAMNESTIC CHARACTERISTICS OF ISCHEMIC HEART DISEASE IN PATIENTS WHO UNDERWENT CORONARY ARTERY BYPASS GRAFTING AND THEIR IMPORTANCE FOR ASSESSING PERIOPERATIVE RISK

    Akobir B. Mukhammedov, Usmon Bebitovich Oltiyev

    MaqolaCardiac, Anesthesia and Surgical OutcomesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  10. CLINICAL AND ANAMNESTIC CHARACTERISTICS OF ISCHEMIC HEART DISEASE IN PATIENTS WHO UNDERWENT CORONARY ARTERY BYPASS GRAFTING AND THEIR IMPORTANCE FOR ASSESSING PERIOPERATIVE RISK

    Akobir B. Mukhammedov, Usmon Bebitovich Oltiyev

    MaqolaCardiac, Anesthesia and Surgical OutcomesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  11. Prognostic Factors And Efficacy Of Antiplatelet Therapy In Patients With Chronic Ischemic Heart Disease

    Tolibjonov Dilmurod Tolibjonovich, Yuldashov Farrux Shuxratovich

    MaqolaBiomarkers in Disease MechanismsFrontline Medical Sciences and Pharmaceutical Journal20250 iqtibos
    ABI

  12. Therapy After Percutaneous Coronary Intervention in Chronic Coronary Disease: A Practical Review for Internal Medicine and Interventional Cardiology

    Akramov Bekhzod Bakhromjon o'gli

    MaqolaLipoproteins and Cardiovascular HealthThe American Journal of Medical Sciences and Pharmaceutical Research20260 iqtibos
    ABI